- NISPA (Nijmegen Institute for Scientist-Practitioners in Addiction)

04-2023

Development of an alcohol refusal training in immersive virtual reality for patients with mild to borderline intellectual disability and alcohol use disorder: cocreation with experts in addiction care

Simon Langener, Jan Kolkmeier, Joanneke van der Nagel, Randy Klaassen, Jeannette van Manen en Dirk Heylen

JMIR Form Res 2023;7:e42523

Lees meer >

04-2023

Psychiatric risk factors for chronic high-dose opioid prescribing: register-based cohort study

Mariëlle van der Hoorn, Arno Kalkman, Yvette Weesie, Femke Atsma en Arnt Schellekens

BJPsych Open.2023 Apr 20;9(3):e74.

Lees meer >

04-2023

Patients' perspectives on the development of prescription opioid use disorder in patients with chronic non-cancer pain

Lisa Davies, Ellen Koster, Katinka Damen, Harmen Beurmanjer, Arnt Schellekens en Marcel L Bouvy

Eur Addict Res. 2023 Apr 14;1-9.

Lees meer >

03-2023

An overview of the putative structural and functional properties of the GHBh1 receptor through a bioinformatics approach

Casper Wolf, Hanka Venselaar, Marcia Spoelder, Harmen Beurmanjer, Arnt Schellekens en Judith Homberg

Life 2023, 13(4), 926

Lees meer >

02-2023

Practice variation in opioid prescribing for non-cancer pain in Dutch primary care: A retrospective database study

Arno Kalkman, Cornelis Kramers, R T van Dongen, Henk Schers , Rianne van Boekel, Anne-Marie Bos, Karin Hek, Arnt Schellekens en Femke Atsma

PLoS One. 2023 feb 24;18(2):e0282222

Lees meer >

02-2023

Therapeutic effect of psilocybin in addiction: A systematic review

Pim van der Meer, Juan Fuentes, Ad Kaptein, Jan Schoones, Marleen de Waal, Anneke Goudriaan, Kees Kramers, Arnt Schellekens, Metten Somers, Matthijs Bossong en Albert Batalla

Front Psychiatry. 2023 Feb 9;14:1134454.

Lees meer >

02-2023

Therapeutic effect of psilocybin in addiction: A systematic review

Pim van der Meer, Juan Fuentes, Ad Kaptein, Jan Schoones, Marleen de Waal, Anneke Goudriaan, Kees Kramers, Arnt Schellekens, Metten Somers, Matthijs Bossong en Albert Batalla

Front Psychiatry. 2023 feb 9;14:1134454.

Lees meer >

01-2023

Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL study

Cornelis Jan van Dam, Monique van Velzen, Cornelis Kramers, Arnt Schellekens, Erik Olofsen, Marieke Niesters en Albert Dahan

Randomized Controlled Trial Trials, 2023, 24(1): 64

Lees meer >

01-2023

Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study

Pauline Geuijen, Arnt Schellekens, Aart Schene en Femke Atsma

Addiction Science Clinical Practice, 2023, 18(1): 4

Lees meer >

12-2022

The 2000HIV study: Design, multi-omics methods and participant characteristics

Wilhelm Vos†, Albert Groenendijk†, Marc Blaauw, Louise van Eekeren, Adriana Navas, Maartje Cleophas, Nadira Vadaq, Vasiliki Matzaraki, Jéssica dos Santos, Elise Meeder, Janeri Fröberg, Gert Weijers, Yue Zhang, Jingyuan Fu, Rob ter Horst, Christoph Bock, Rainer Knoll, Anna Aschenbrenner, Joachim Schultze, Linos van der kerckhove, Talent Hwandih, Elizabeth Wonderlich, Sai Vemula, Mike van der Kolk, Sterre de Vet, Willem Blok, Kees Brinkman, Casper Rokx, Arnt Schellekens, Quirijn de Mast, Leo Joosten, Marvin Berrevoets, Janneke Stalenhoef, Annelies Verbon, Jan van Lunzen, Mihai Netea en Andre van der Ven

Front. Immunol., 20 December 2022, sec. viral immunology, volume 13 - 2022 |

Lees meer >

11-2022

Effect of past pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on substance use disorder

Corné Coetzee, Arnt Schellekens, Ilse Truter en Anneke Meyer

European Addiction Resource, 2023, 29(1): 9-18

Lees meer >

10-2022

The North American opioid crisis: a European perspective

Arno Kalkman, Cornelis Kramers, Wim van den Brink en Arnt Schellekens

The Lancet Journal, volume 400, issue 10361, P1404, october 22, 2022

Lees meer >

09-2022

Trippen of skippen? Resultaten monitor 2021 - determinanten en normalisering van drugsgebruik

Boukje Dijkstra, Mieke van Duijnhoven, Linda van Tilburg, Gemma Smulders en Daniëlle Ketelaars

Oost-Brabant: regioproject drugs ‘SKIP’

Lees meer >

09-2022

Detoxificatie tijdens de zwangerschap, een update

Michiel van Kernebeek, Boukje Dijkstra, Titia Hompes, Cleo Crunelle en Frieda Matthys

Tijdschrift Verslaving & Herstel, 2022, 2(2)

Lees meer >

09-2022

Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial

Hannah Ellerbroek, Sandra van den Heuvel, Albert Dahan, Hans Timmerman, Cornelis Kramers en Arnt Schellekens

Addiction Science & Clinical Practice, 2022, 17 (47)

Lees meer >